Written By: Natasha Khrystolubova, RPh, BCOP, Florida Cancer Specialists and Jody Agena, PharmD, Virginia Cancer Specialists
This PQI is intended to address effective practices for the management of alpelisib induced hyperglycemia by focusing on a multidisciplinary approach.
Continue reading Management of Alpelisib (Piqray®) Induced Hyperglycemia
Written By: Natasha Olson, PharmD, NCODA
The purpose of this PQI is to provide proper identification and management of patients who may benefit from the use of non-hormonal contraception using lactic acid/citric acid/potassium bitartrate (Phexxi®), a novel non-hormonal, vaginal pH modulator.
Continue reading Non-hormonal Birth Control Alternative with Lactic acid/Citric acid/Potassium Bitartrate (Phexxi®)
Written By: Autumn Alvarez, PharmD, BCPS, Blue Ridge Cancer Care
The purpose of this PQI is to describe the indication, pharmacology and dosing of trilaciclib.
Continue reading Trilaciclib (Cosela™) Management